SYNAPTIXBIO
SynaptixBio is developing lifesaving therapies for severe leukodystrophies. The company enables the translation of ground-breaking research in TUBB4a Leukodystrophy into a transformative therapy. Their updated news is imported into the website. The customer queries are addressed through an online form.
SYNAPTIXBIO
Social Links:
Industry:
Biotechnology Genetics Therapeutics
Founded:
2021-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.synaptixbio.com
Total Employee:
1+
Status:
Active
Total Funding:
11.54 M GBP
Technology used in webpage:
Google Google Cloud Pound Sterling Wix
Similar Organizations
Beren Therapeutics
Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.
IntegraGen
IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.
Ochre Bio
Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.
ReViral
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
Current Employees Featured
Founder
Investors List
Innovate UK
Innovate UK investment in Grant - SynaptixBio
Official Site Inspections
http://www.synaptixbio.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "SynaptixBio"
SynaptixBio | the team
SynaptixBio was founded in 2021 to enable translation of ground-breaking research in TUBB4a Leukodystrophy into a transformative therapy. Therapeutic development is based onto novel science conceived in the …See details»
SynaptixBio Ltd. - LinkedIn
SynaptixBio Ltd. | 2,554 followers on LinkedIn. Developing therapies for severe leukodystrophies | Overview SynaptixBio is a rare disease biotech company that is pioneering ground-breaking ...See details»
SynaptixBio - Crunchbase Company Profile & Funding
SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.See details»
SynaptixBio 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for SynaptixBio. Use the PitchBook Platform to explore the full profile.See details»
SynaptixBio - 2025 Company Profile & Team - Tracxn
Jun 23, 2025 SynaptixBio is a seed company based in Oxford (United Kingdom), founded in 2021 by Bent Jakobsen and Michelle Teng. It operates as a Developer of gene therapies for …See details»
SYNAPTIXBIO LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SYNAPTIXBIO LTD of OXFORD. Get the latest business insights from Dun & Bradstreet.See details»
SynaptixBio - Products, Competitors, Financials, Employees ...
About SynaptixBio SynaptixBio is a biotechnology company focused on developing therapies for severe leukodystrophies. The company specializes in gene therapies aimed at treating fatal …See details»
SynaptixBio Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 SynaptixBio is focused intently on halting this disease. Currently, the company is looking at the relatively limited research in the literature and finding ways to incorporate the …See details»
SynaptixBio - Financial Details - Crunchbase
SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.See details»
SynaptixBio | the opportunity
SynaptixBio has come a long way in just a few short years. We are now opening up new investment opportunities for others to join our mission and support SynaptixBio’s life changing …See details»
SynaptixBio | the science
SynaptixBio is a rare disease biotech pioneering ground-breaking development for treatment of severe leukodystrophies. Leukodystrophies affect the brain and manifest with a spectrum of severity and symptoms. …See details»
Focus on: SynaptixBio - pharmiweb.jobs
Jun 26, 2025 SynaptixBio is a UK-based biotechnology company pioneering gene therapies for rare and fatal leukodystrophies, particularly those linked to TUBB4A mutations. Founded in …See details»
SYNAPTIXBIO LTD overview - Find and update company …
SYNAPTIXBIO LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»
SynaptixBio Ltd. - app.biopharmiq.com
About: SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. …See details»
SynaptixBio Ltd. - BIO International Convention 2025
SynaptixBio is a rare disease biotech pioneering ground-breaking development for treatment of severe leukodystrophies. Leukodystrophies affect the brain and manifest with a spectrum of …See details»
Orphanet: SYNAPTIXBIO LTD.
SynaptixBio Ltd. SynaptixBio Ltd. 9400 Garsington Road, Oxford Business Park OX4 2HN OXFORD UNITED KINGDOMSee details»
SynaptixBio: Four Years Of Rare Disease Research Excellence | The ...
Oxford-based biotech company SynaptixBio is celebrating four years of groundbreaking research into rare genetic disorders.See details»
SynaptixBio - Profiles & Contacts - Crunchbase
SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.See details»
SynaptixBio - Contacts, Employees, Board Members, Advisors
SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.See details»
SynaptixBio Readying to Take First Antisense Oligonucleotide …
Jul 31, 2024 NEW YORK – UK startup SynaptixBio has ambitions to enter the antisense oligonucleotide (ASO) space by developing treatments for rare leukodystrophies. The …See details»